Development of Quantitative Enzyme Immunoassay of Brain-Derived Neurotrophic Factor on the Basis of Recombinant Antigen

O. V. Pavlova; Павлова О. В.; A. A. Murashko; Мурашко А. А.; N. V. Andriushchenko; Андрющенко Н. В.; O. I. Gurina; Гурина О. И.; K. A. Pavlov; Павлов К. А.

doi:10.31857/S1027813323010156

Development of Quantitative Enzyme Immunoassay of Brain-Derived Neurotrophic Factor on the Basis of Recombinant Antigen

Авторлар: Pavlova O.V.¹, Murashko A.A.², Andriushchenko N.V.¹, Gurina O.I.¹, Pavlov K.A.¹
Мекемелер:
1. Serbsky National Medical Research Centre for Psychiatry and Narcology
2. Moscow Research Institute of Psychiatry – the Branch of Serbsky National Medical Research Centre for Psychiatry and Narcology
Шығарылым: Том 40, № 1 (2023)
Беттер: 86-91
Бөлім: МЕТОДЫ
URL: https://vietnamjournal.ru/1027-8133/article/view/653960
DOI: https://doi.org/10.31857/S1027813323010156
EDN: https://elibrary.ru/EQWZUP
ID: 653960

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат
Рұқсат жабық

Рұқсат берілді
Рұқсат жабық

Тек жазылушылар үшін

Аннотация
Авторлар туралы
Әдебиет тізімі
Қосымша файлдар
Статистика

Аннотация

One of the pathophysiological mechanisms of the development of some mental diseases, including depressive disorders, is a decrease in the expression of brain-derived neurotrophic factor (BDNF), mainly in the limbic region and prefrontal cortex of the brain. Immunochemical screening of BDNF in biological fluids showed that the levels of this protein can be considered as a marker of predisposition to depression and a prognostic marker of the effectiveness of therapy. The use of modern technologies for the production of recombinant proteins makes it possible to develop highly standardized ELISA systems for the determination of this antigen in biological fluids. This paper describes a method for creating a test system for quantitative ELISA of brain-derived neurotrophic factor on the basis of recombinant protein BDNF and antibodies obtained as a result of immunization with recombinant BDNF.

Негізгі сөздер

brain-derived neurotrophic factor, monoclonal antibodies, recombinant protein, ELISA, depressive disorders

Әдебиет тізімі

Kessler R.C., Bromet E.J. // Annu. Rev. Public. Health. 2013. V. 34. P. 113–138.https://doi.org/10.1146/annurev-publhealth-031912-114409
Stetler C., Miller G.E. // Psychosom. Med. 2011. V. 73. № 2. P. 114–126. https://doi.org/10.1097/PSY.0b013e31820ad12b
Irwin M.R., Miller A.H. // Brain Behav. Immun. 2007 V. 21. № 4. P. 374–383. https://doi.org/10.1016/j.bbi.2007.01.010
Григорьян Г.А., Дыгало Н.Н., Гехт А.Б., Степаничев М.Ю., Гуляева Н.В. // Усп. физиол. наук. 2014. Т. 43. № 2. С. 3–19.
Sullivan P.F., Agrawal A., Bulik C.M., Andreassen O.A., Borglum A.D., Breen G., Cichon S., Edenberg H.J., Faraone S.V., Gelernter J., Mathews C.A., Nievergelt C.M., Smoller J.W., O’Donovan M.C. // Am. J. Psychiatry. 2018. V. 175. № 1. P. 15–27. https://doi.org/10.1176/appi.ajp.2017.17030283
Yang T., Nie Z., Shu H., Kuang Y., Chen X., Cheng J., Yu S., Liu H. // Front. Cell Neurosci. 2020. V. 14. P. 82. https://doi.org/10.3389/fncel.2020.00082.eCollection 2020
Barde Y.A., Edgar D., Thoenen H. // EMBO J. 1982. V. 1. № 5. P. 549–53.
Kowianski P., Lietzau G., Czuba E., Waskow M., Steliga A., Morys J. // Cell Mol. Neurobiol. 2018. V. 38. P. 579–593.https://doi.org/10.1007/s10571-017-0510-4
Гуляева Н.В. // Биохимия. 2017. Т. 82. Bып. 3. С. 441–448.
Taliaz D., Stall N., Dar D.E, Zangen A.// Mol. Psychiatry. 2010. V. 15. № 1. P. 80–92. https://doi.org/10.1038/mp.2009.67
Filho C.B., Jesse C.R., Donato F., Giacomeli R., Del Fabbro L., da Silva Antunes M., de Gomes M.G., Goes A.T., Boeira S.P., Prigol M., Souza L.C. // Neuroscience. 2015. V. 289. P. 367–380. https://doi.org/10.1016/j.neuroscience.2014.12.048
Yoshida T., Ishikawa M., Niitsu T., Nakazato M., Watanabe H., Shiraishi T., Shiina A., Hashimoto T., Kanahara N., Hasegawa T., Enohara M., Kimura A., Iyo M., Hashimoto K. // PLoS One. 2012. V. 7. № 8. e42676. https://doi.org/10.1371/journal.pone.0042676
Duman R.S., Aghajanian G.K., Sanacora G., Krystal J.H. // Nat. Med. 2016. V. 23. № 3. P. 238–249. https://doi.org/10.1038/nm.4050
Duman R.S., Deyama S., Fogaça M.V. // Eur. J. Neurosci. 2021. V. 53. № 1. P. 126–139. https://doi.org/10.1111/ejn.14630
Mondal A.C., Fatima M. // Int. J. Neurosci. 2019. V. 129. № 3. P. 283–296. https://doi.org/10.1080/00207454.2018.1527328
Castren E., Kojima M. // Neurobiol. Dis. 2017. V. 97. P. 119–126. https://doi.org/10.1016/j.nbd.2016.07.010
Nobis A., Zalewski D., Waszkiewicz N. // J. Clin. Med. 2020. V. 9. 3793. https://doi.org/10.3390/jcm9123793
Islam F., Mulsant B.H., Voineskos A.N., Rajji T.K. // Curr. Psychiatry Rep. 2017. V. 19. № 7. P. 36. https://doi.org/10.1007/s11920-017-0794-6
Song J.H., Yu J.T., Tan L. // Mol. Neurobiol. 2015. V. 52. № 3. P. 1477–1493. https://doi.org/10.1007/s12035-014-8958-4
Nuernberg G.L., Aguiar B., Bristot G., Fleck M.P., Rocha N.S. // Transl. Psychiatry. 2016. V. 6. № 12. e985. https://doi.org/10.1038/tp.2016.227
Jin W. // J. Clin. Med. 2020. V. 9. № 1. P. 257. https://doi.org/10.3390/jcm9010257